Livingston, Scotland – March 4, 2015 – Touch Bionics, a provider of world-leading upper limb prosthetic technologies, today announced that it has appointed Dr John Brown CBE as Chairman, succeeding Professor George Borthwick CBE, who is retiring from the Board of Directors.
Dr Brown is Chairman of ProStrakan Group plc, CXR Biosciences Ltd, Mode Diagnostics Ltd and the Cell Therapy Catapult. He is a non-executive Director of Vectura Group plc and was previously Chairman of BTG plc, and Axis-Shield plc.
In the public sector, Dr Brown chairs the Roslin Foundation and the Easter Bush Development Board and co-Chairs the Life Sciences Industry Advisory Board for the Scottish Government. He is an advisor to several private equity and venture capital funds, a Fellow of the Royal Society of Edinburgh and Honorary Professor of the University of Edinburgh.
Dr Brown said: ‘On behalf of Touch Bionics I would like to thank George for all his excellent work as Chairman. I am very pleased to be taking on this role and look forward to growing this exciting world leading business.’
About Touch Bionics
Touch Bionics is a provider of world-leading prosthetic technologies designed to achieve positive outcomes for people with upper limb deficiencies. Touch Bionics was the first company to develop an electrically powered prosthetic hand with five independently powered fingers and the company continues to be a pioneer in upper limb prosthetic solutions. The company's products include electronic prosthetic hand and prosthetic finger solutions, as well as passive silicone prostheses that closely match the natural appearance of the wearer.
A spin-out from the UK’s National Health Service, Touch Bionics was founded by inventor David Gow and is funded and supported by Archangel Investors Limited and Scottish Enterprise.